Oramed Pharm (ORMP) Stock Forecast & Price Target
ORMP Analyst Ratings
There are no analyst ratings in the last 3 months.
ORMP Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | ILA 1,415.05→ILA 1,257.83 | hold | -4.06%Downside | Reiterated | 10/31/26 | ||
| Google Biotechnology | TipRanks - Google | ILA 1,415.05 | hold | 7.94%Upside | Reiterated | 10/31/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | ILA 1,415.05→ILA 1,257.83 | hold | -4.06%Downside | Reiterated | 10/31/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | ILA 1,415.05→ILA 1,257.83 | hold | -4.06%Downside | Reiterated | 10/31/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | ILA 1,415.05 | hold | 7.94%Upside | Reiterated | 10/31/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | ILA 1,415.05 | buy | 7.94%Upside | Reiterated | 10/31/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/31/26 | ILA 1,415.05→ILA 1,257.83 | hold | -4.06%Downside | Reiterated | TipRanks - PerPlexity | ||
| Google Biotechnology | 10/31/26 | ILA 1,415.05 | hold | 7.94%Upside | Reiterated | TipRanks - Google | ||
| Anthropic Biotechnology | 10/31/26 | ILA 1,415.05→ILA 1,257.83 | hold | -4.06%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/31/26 | ILA 1,415.05→ILA 1,257.83 | hold | -4.06%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/31/26 | ILA 1,415.05 | hold | 7.94%Upside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/31/26 | ILA 1,415.05 | buy | 7.94%Upside | Reiterated | TipRanks - xAI |
Best Analysts Covering Oramed Pharm
Copying xAi Biotechnology's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -7.00% per trade.
Copying xAi Biotechnology's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -8.80% per trade.
Copying xAi Biotechnology's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -8.80% per trade.
ORMP Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, ORMP has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ORMP average Analyst price target in the past 3 months is ―.
ORMP Financial Forecast
ORMP Earnings Forecast
Next quarter’s earnings estimate for ORMP is ILA 867.90 with a range of ― to ―. The previous quarter’s EPS was ILA 867.90. ORMP beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ORMP has Performed in-line its overall industry.
ORMP Sales Forecast
Next quarter’s sales forecast for ORMP is ILA 0 with a range of ― to ―. The previous quarter’s sales results were ILA 0. ORMP beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ORMP has Performed in-line its overall industry.